Skip to main content
SpringerLink
Log in

Behandelbare neuromuskuläre Erkrankungen als wichtige Differentialdiagnose der chronisch-progredienten Dyspnoe im höheren Erwachsenenalter

Treatable neuromuscular diseases as important differential diagnoses of chronic dyspnea in adulthood

  • Bild und Fall
  • Published:
Der Pneumologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Toscano A, Schoser B (2013) Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260:951–959

    Article  CAS  PubMed  Google Scholar 

  2. Schuller A, Wenninger S, Strigl-Pill N et al (2012) Toward deconstructing the phenotype of late-onset Pompe disease. Am J Med Genet C Semin Med Genet 160C:80–88

    Article  PubMed  Google Scholar 

  3. Pfeffer G, Povitz M, Gibson GJ et al (2015) Diagnosis of muscle diseases presenting with early respiratory failure. J Neurol 262:1101–1114

    Article  PubMed  Google Scholar 

  4. Yuan N (2012) Neuromuscular disease and the pulmonologist. Curr Opin Pediatr 24:336–343

    Article  PubMed  Google Scholar 

  5. Manganelli F, Ruggiero L (2013) Clinical features of Pompe disease. Acta Myol 32:82–84

    PubMed Central  CAS  PubMed  Google Scholar 

  6. Lukacs Z, Nieves Cobos P, Mengel E et al (2010) Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possibility for newborn screening. J Inherit Metab Dis 33:43–50

    Article  CAS  PubMed  Google Scholar 

  7. Patel TT, Banugaria SG, Case LE et al (2012) The impact of antibodies in late-onset Pompe disease: a case series and literature review. Mol Genet Metab 106:301–309

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. S. Wenninger gibt an, dass kein Interessenkonflikt besteht. B. Schoser erhielt Honorare für Fortbildungsvorträge der Firma Genzyme-Sanofi.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Friedrich-Baur-Institut, Neurologische Klinik, Interdisziplinäres Zentrum für Neuromuskuläre Erkrankungen, Klinikums der Universität München, Ziemssenstr. 1a, 80336, München, Deutschland

    S. Wenninger & B. Schoser

Authors
  1. S. Wenninger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Schoser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Wenninger.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wenninger, S., Schoser, B. Behandelbare neuromuskuläre Erkrankungen als wichtige Differentialdiagnose der chronisch-progredienten Dyspnoe im höheren Erwachsenenalter. Pneumologe 12, 420–425 (2015). https://doi.org/10.1007/s10405-015-0922-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-015-0922-0

Search

Navigation